| Product Code: ETC12838639 | Publication Date: Apr 2025 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Israel continued to source influenza medications primarily from Switzerland, UK, Belgium, USA, and Germany. The market remained highly competitive with a low Herfindahl-Hirschman Index (HHI) concentration, indicating a diverse range of suppliers. However, the market saw a slight decline with a negative Compound Annual Growth Rate (CAGR) of -2.14% from 2020 to 2024. The growth rate further decreased in 2024, with a -0.41% change from the previous year. Israel`s import shipments of influenza medications reflect a dynamic market landscape influenced by global trends and supplier dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Influenza Medications Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Influenza Medications Market - Industry Life Cycle |
3.4 Israel Influenza Medications Market - Porter's Five Forces |
3.5 Israel Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Israel Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Israel Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Israel Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination |
4.2.2 Rising prevalence of influenza cases in Israel |
4.2.3 Technological advancements in influenza medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for influenza medications |
4.3.2 High competition among manufacturers and pharmaceutical companies |
5 Israel Influenza Medications Market Trends |
6 Israel Influenza Medications Market, By Types |
6.1 Israel Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Israel Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Israel Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Israel Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Israel Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Israel Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Israel Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Israel Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Israel Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Israel Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Israel Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Israel Influenza Medications Market Import-Export Trade Statistics |
7.1 Israel Influenza Medications Market Export to Major Countries |
7.2 Israel Influenza Medications Market Imports from Major Countries |
8 Israel Influenza Medications Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination rates in Israel |
8.2 Number of reported influenza cases in Israel |
8.3 Adoption rate of new technologies in influenza medications |
9 Israel Influenza Medications Market - Opportunity Assessment |
9.1 Israel Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Israel Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Israel Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Israel Influenza Medications Market - Competitive Landscape |
10.1 Israel Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Israel Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here